SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : sciclone pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Oak Tree who wrote (901)8/22/2001 9:41:19 PM
From: JEB  Read Replies (2) | Respond to of 1137
 
You referred to the ASCO meeting. I posted the ASCO meeting link.



To: Oak Tree who wrote (901)8/22/2001 11:02:08 PM
From: JEB  Respond to of 1137
 
You're link to this radiotherapy trial was published August 2000. The ASCO meeting was in July of the same year (one month prior). You can't "misstate" what is the current standard of care for the industry (in fact, the August study would be considered experimental as of the July publishing date).

ncbi.nlm.nih.gov

jama.ama-assn.org

Since you are a doctor, you already know this, ...right?



To: Oak Tree who wrote (901)8/25/2001 9:03:03 AM
From: JEB  Read Replies (1) | Respond to of 1137
 
Since you are a doctor, please explain to the good people here how a clinical trial protocol is developed and under what rules and objectives are the controls of the study.

Also, is experimental theory (i.e. a new radiotherapy clinical trial protocol) allowed to be used as one of the controls of the study?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News